Table 1 Noninvasive ventilation rate and application across included countries
From: Noninvasive ventilation in COVID-19 patients aged ≥ 70 years—a prospective multicentre cohort study
Country | Number of patients | Number of patients using NIV | NIV rate % (95% CI) | NIV application | |
|---|---|---|---|---|---|
Primary NIV | Post-extubation NIV | ||||
Austria | 40 | 10 | 25.0% (12.7–41.2%) | 9 (90.0) | 1 (10.0) |
Belgium | 174 | 2 | 1.1% (0.1–4.1%) | 2 (100.0) | 0 (0.0) |
Denmark* | 215 | 73 | 34.0% (27.7–40.7%) | 66 (90.4) | 6 (8.2) |
England | 172 | 94 | 54.7% (46.9–62.2%) | 89 (94.7) | 5 (5.3) |
France | 699 | 170 | 24.3 (21.2–27.7%) | 124 (72.9) | 46 (27.1) |
Germany* | 284 | 141 | 49.6% (43.7–55.6%) | 124 (87.9) | 15 (10.6) |
Greece | 130 | 36 | 27.7% (20.2–36.2%) | 19 (52.8) | 17 (47.2) |
Israel | 58 | 20 | 34.5% (22.5–48.1%) | 15 (75.0) | 5 (25.0) |
Netherlands | 338 | 11 | 3.3% (1.6–5.8%) | 7 (63.6) | 4 (36.4) |
Norway | 23 | 12 | 52.2% (30.6–73.2%) | 12 (100.0) | 0 (0.0) |
Poland | 129 | 4 | 3.1% (0.9–7.8%) | 2 (50.0) | 2 (50.0) |
Portugal | 91 | 48 | 52.7% (42.0–63.3%) | 39 (81.3) | 9 (18.7) |
Spain* | 408 | 46 | 11.3% (8.4–14.8%) | 30 (66.0) | 15 (34.0) |
Switzerland | 263 | 93 | 35.4% (29.6–41.5%) | 63 (67.7) | 30 (32.3) |
Wales | 50 | 31 | 62.0% (47.2–75.4%) | 29 (93.5) | 2 (6.5) |